BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Breaking News: BioWorld Science 2025 Year in Review
Breaking News: BioWorld 2025 Year in Review
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Conferences
BioWorld Science, Conferences
RSS
Interim phase II data presented on vorinostat/gemtuzumab ozogamicin in AML
June 21, 2010
AFQ-056 reduces levodopa-induced dyskinesia in Parkinson's disease
June 21, 2010
CEP cells show promise as biomarker for response to antiangiogenic therapy in CRPC
June 18, 2010
AZD-6244 is beneficial in phase II trial in IRPTC and PTC
June 18, 2010
SRX-251 shows favorable safety, tolerability and pharmacokinetics in healthy subjects
June 18, 2010
Final phase II data on voreloxin/cytarabine in AML support phase III testing
June 18, 2010
Pramipexole ER shows long-term efficacy and safety in advanced Parkinson's disease
June 18, 2010
Long-term pimavanserin safe and well tolerated in Parkinson's disease psychosis
June 18, 2010
SCH-900105 is safe and advances from phase I to phase II trial
June 17, 2010
Idarubicin/busulphan improves outcome of autograft in patients with NPM1-mutant AML
June 17, 2010
Previous
1
2
…
1435
1436
1437
1438
1439
1440
1441
1442
1443
…
3070
3071
Next
RSS